James Reuberson

CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors

Rakki P. Alexander, Graham J. Warrellow, Michael A. W. Eaton et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 57 citations · Full text

A Prototype, Medicine, Immunology +8

Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase

John Porter, Simon Lumb, Fabien Lecomte et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 50 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, C-met Kinase +11

Discovery of 4-azaindoles as novel inhibitors of c-Met kinase

John Porter, Simon Lumb, Richard J. Franklin et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 38 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, C-met Kinase +4

Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists

Nicholas D. Kindon, Glen K. Andrews, Andrew Baxter et al. · ACS Medicinal Chemistry Letters · 2017 · 29 citations · Full text

Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment <i>in Vivo</i>

James Reuberson, Helen Horsley, Richard J. Franklin et al. · Journal of Medicinal Chemistry · 2018 · 20 citations · Full text

Pharmaceutical Science, Drug Target, Therapeutics +20